Anti-Snoring Treatment Market Size, Trends, Share, Growth and Forecast 2022-2027 – Instant Interview

The latest research studyAnti-Snoring Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global anti-snoring treatment market size reached US$1.34 billion in 2021. IMARC Group expects the market to reach a value of US$2.29 billion by 2027 growing at a CAGR of 9.10% during the period 2022-2027.

Download a free sample PDF for more detailed market information https://www.imarcgroup.com/anti-snoring-treatment-market/requestsample

REMARK: We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Snoring refers to loud breath sounds coming from an individual’s nose or mouth. It occurs when the soft tissues of the throat partially obstruct the airways and produce vibrations. It is medically treated with surgery or continuous positive airway pressure (CPAP), in which a mask is worn over the nose or mouth and connected to a machine to deliver a steady stream of air into the nostrils. It can also be cured by lifestyle changes, such as changing sleeping positions, avoiding alcohol, sedatives, maintaining body weight, and relieving nasal obstruction.

anti-snoring treatment market Trends and Drivers:

The market is primarily driven by various technological advancements in anti-snoring treatment devices. Additionally, the growing awareness of individuals regarding the long-term adverse effects of snoring, such as the risk of developing hypertension, stroke, type 2 diabetes, fatigue, heart attacks, and decreased blood oxygen levels, represents another key contributing factor to the market. growth.

Apart from this, loud and frequent snoring is one of the signs of Obstructive Sleep Apnea (OSA), which can lead to cancer, glaucoma, cognitive and behavioral impairments and road accidents. As a result, individuals are widely embracing anti-snoring treatment solutions. This, coupled with the increasing use of anti-snoring apps, tongue stabilization devices (TSDs), behavioral therapies, dental devices and mandibular advancement devices (MADs), also known as advancement therapy (JAD), for treating snoring, is positively influencing the growth of the market.

Other factors including increasing tobacco and alcohol consumption among individuals and increasing prevalence of sleep disorders are also creating favorable market prospects across the globe.

Ask the analyst to customize and explore the full report with table of contents and list of figures: https://www.imarcgroup.com/request?type=report&id=5887&flag=C

Scope of the Anti-Snoring Treatment Market Report
Report cover Details
Market size value in 2021 US$1.34 billion
Market forecast in 2027 US$2.29 billion
Rate of growth CAGR of 9.10% from 2022 to 2027
Base year for the estimate 2021
Historical data 2016-2021
Forecast period 2022-2027
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Segments Covered Device type and distribution channel.
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Profiled Key Companies Airway Management Inc., Apnea Sciences Corporation, Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips NV, MEDiTAS Ltd., Medtronic plc, Mitsui Chemicals Inc., ResMed Inc., Rotech Healthcare Inc., SomnoMed, The Pure Sleep Company and Tomed GmbH .
Market dynamics Parent Market Analysis, Market Growth Drivers and Barriers, Fast and Slow Growing Segment Analysis, COVID 19 Impact and Future Consumer Dynamics, Market Condition Analysis for the Forecast Period,
Personalization area If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the major players operating in the market.

Airway Management Inc., Apnea Sciences Corporation, Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips NV, MEDiTAS Ltd., Medtronic plc, Mitsui Chemicals Inc., ResMed Inc., Rotech Healthcare Inc., SomnoMed, The Pure Sleep Company and Tomed GmbH .

Ask before buying: https://www.imarcgroup.com/request?type=report&id=5887&flag=F

The report has segmented the market on the basis of device type, distribution channel and geography

Breakdown by device type:

  • Mandibular Advancement Devices (MADs)
  • Tongue Stabilizer Devices (TSD)
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Others

Breakdown by distribution channel:

  • Hospital pharmacies
  • Retail pharmacies
  • On line
  • Others

By geography:

  • North America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
  • Middle East and Africa

Browse other reports:

costume jewelry market

Purified Terephthalic Acid (PTA) Market

commercial drone market

industrial engine market

Surgical Equipment Market

About Us:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Contact us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, Wyoming 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Such. :(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800